Patent details

90614 Product Name: LANTUS-insulin glargine

Basic Information

Publication number:
90614
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP891204620
Legal Status:
Expired
Application number:
90614
First applicant's nationality:
Procedural language:
French

Paediatric Extension

SPC Extension Filing Date:
25/07/2012
SPC Extension Agent Name:
OFFICE FREYLINGER S.A. , SANOFI-AVENTIS DEUTSCHLAND GMBH
SPC Extension Status:
Granted
SPC Extension Grant Date:
06/02/2014
SPC Extension Rejection Date:

Marketing Authorization

Marketing Authorization Number:
EU/1/00/134/001 à 007
Marketing Authorization Type:
Marketing Authorization Date:
09/06/2000
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
26/07/2000
First Marketing Authorization date:
09/06/2000
Grant date:
26/09/2000
Activation date:
06/11/2009
Publication date:
26/09/2000
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
06/11/2014
SPC Extension Expiration:
06/05/2015
Rejection date:
Withdrawal date:

Owner

From:
19/10/2005
 
 

Name:
SANOFI-AVENTIS DEUTSCHLAND GMBH
Address:
BRÜNINGSTRASSE 50, 65929, FRANKFURT, Germany (DE)

History of Owners

From:
07/08/2002
To:
18/10/2005

Name:
AVENTIS PHARMA DEUTSCHLAND GMBH
Address:
BRÜNINGSTRASSE 50, 65929, FRANKFURT, Germany (DE)

From:
26/07/2000
To:
06/08/2002

Name:
HOECHST AKTIENGESELLSCHAFT
Address:
-, 65926, FRANKFURT AM MAIN, Germany (DE)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
26/07/2000
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:
Filing date Document type Number of pages